Topiramate diminishes fear memory consolidation and extinguishes conditioned fear in rats

Journal of Psychiatry and Neuroscience

Volumn 36, Issue 4, 2011, Pages 250-253

  do Prado Lima, Pedro Antônio Schmidt ^a   Perrenoud, Myriam Fortes ^a   Kristensen, Christian Haag ^a   Cammarota, Martin ^a   Izquierdo, Ivan ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

TOPIRAMATE;

ANIMAL EXPERIMENT; ARTICLE; AVERSION; AVOIDANCE BEHAVIOR; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL DESIGN; FEAR; MALE; MEMORY CONSOLIDATION; NONHUMAN; RAT; SINGLE DRUG DOSE;

EID: 79959678087     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.100115     Document Type: Article

References (29)

1. Gryder DS, Rogawski MA. Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons. J Neurosci 2003;23:7069-7074.
2. Sun MK, Alkon DL. Carbonic anhydrase gating of attention: memory therapy and enhancement. Trends Pharmacol Sci 2002;23:83-89.
3. Lee HW, Jung DK, Suh CK, et al. Cognitive effects of low-dose topiramate monotherapy in epilepsy patient: a 1-year follow-up. Epilepsy Behav 2006;8:736-741.
4. Johnson BA, Ait-Daoud N, Bowden CL, et al. Oral topiramate for treatment of alcohol dependence: a randomized controlled trial. Lancet 2003;361:1677-1685.
5. McElroy SL, Hudson JI, Capece JA, et al. Topiramate for treatment of binge eating disorder associated with obesity: a placebo- controlled study. Biol Psychiatry 2007;61:1039-48.
6. Schmidt do Prado-Lima PA, Bacaltchuck J. Topiramate in treatment-resistant depression and binge-eating disorder. Bipolar Disord 2002;4:271-273.
7. Tucker P, Trautman RP, Wyatt DB, et al. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2007;68:201-206.
8. Bracha HS. Human brain evolution and the "neuroevolutionary time-depth principle:" implications for the reclassification of fear-circuitry-related traits in DSM-V and for studying re silience to warzone-related posttraumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:827-853.
9. Bradley R, Jenei J, Westen D. Etiology of borderline personality disorder: disentangling the contributions of intercorrelated antecedents. J Nerv Ment Dis 2005;193:24-31.
10. do Prado-Lima P, Kristensen CH, Bacaltchuck J. Can childhood trauma predict response to topiramate in borderline personality disorder? J Clin Pharm Ther 2006;31:193-196.
11. Izquierdo I, Bevilaqua LRM, Rossato JI, et al. Different molecular cascades in different sites of the brain control memory consolidation. Trends Neurosci 2006;29:496-505.
12. Riedel G, Platt B, Micheau J. Glutamate receptor function in learning and memory. Behav Brain Res 2003;140:1-47.
13. Collin C, Devane WA, Dahl D, et al. Long-term synaptic trans formation of hippocampal CA1 gamma-aminobutyric acid synapses and the effect of anandamide. Proc Natl Acd Sci U S A 1995; 92: 10167-10171.
14. Sun MK, Alkon DL. Pharmacological enhancement of synaptic efficacy, spatial learning, and memory through carbonic anhydrase activation in rats. J Pharmacol Exp Ther 2001;297:961-967.
15. - exchange. Br J Pharmacol 2004;142:831-842.
16. Sun MK, Zhao WK, Nelson TJ, et al. Theta rhythm of hyppocampal CA1 neuron activity: gating by GABAergic synaptic depolarization. J Neurophysiol 2001;85:269-279.
17. Sotres-Bayon F, Cain CK, LeDoux JE. Brain mechanisms of fear extinction: historical perspectives on the contribution of prefrontal cortex. Biol Psychiatry 2006;60:329-336.
18. Bouton ME, Westbrook RF, Corcoran KA, et al. Contextual and temporal modulation of extinction: behavioral and biological mechanisms. Biol Psychiatry 2006;60:352-360.
19. Kuzniecky R, Ho S, Pan J, et al. Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology 2002;58:368-372.
20. White HS, Brown SD, Woodhead JH, et al. Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia 2000;41 Suppl 1:S17-S20.
21. Quirk GJ, Garcia R, González-Lima F. Prefrontal mechanisms in extinction of conditioned fear. Biol Psychiatry 2006;60:337-343.
22. Barad M, Gean PW, Lutz B. The role of the amygdala in the extinction of conditioned fear. Biol Psychiatry 2006;60:322-328.
23. Aroniadou-Anderjaska V, Qashu F, Braga MFM. Mechanisms regu lating GABAergic inhibitory transmission in the basolateral amygdala: implications for epilepsy and anxiety disorders. Amino Acids 2007;32:305-315.
24. Akirav I, Raizel H, Maroun M. Enhancement of conditioned fear extinction by infusion of the GABAA agonist muscimol into the rat prefrontal cortex and amygdala. Eur J Neurosci 2006;23:758-764.
25. Akirav I, Maroun M. The role of the medial prefrontal cortex- amygdala circuit in stress effects on the extinction of fear. Neural Plast 2007;2007:30873.
26. Cammarota M, Bevilaqua LRM, Barros DM, et al. Retrieval and the extinction of memory. Cell Mol Neurobiol 2005;25:465-474.
27. Barros DM, Izquierdo LA, Mello e Souza T, et al. Molecular signaling pathways in the cerebral cortex are required for retrieval of one-trial avoidance learning in rats. Behav Brain Res 2000;114:183-192.
28. Roozendaal B. Stress and memory: opposing effects of glucocortic oids on memory consolidation and memory retrieval. Neurobiol Learn Mem 2002;78:578-595.
29. Tsoory MM, Vouimba RM, Akirav I, et al. Amygdala modulation of memory-related processes in the hippocampus: potential relevance to PTSD. Prog Brain Res 2008;167:35-51.